60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP – Get Free Report) was the target of a large drop in short interest during the month of February. As of February 28th, there was short interest totalling 14,600 shares, a drop of 38.7% from the February 13th total of 23,800 shares. Based on an average trading volume of 473,200 shares, the days-to-cover ratio is presently 0.0 days. Approximately 1.2% of the company’s shares are sold short.
60 Degrees Pharmaceuticals Stock Performance
Shares of SXTP stock opened at $1.89 on Monday. The company has a market capitalization of $2.78 million, a P/E ratio of -0.19 and a beta of 4.52. The company’s 50 day moving average price is $3.26 and its two-hundred day moving average price is $4.95. 60 Degrees Pharmaceuticals has a 52 week low of $1.41 and a 52 week high of $35.99.
Analyst Upgrades and Downgrades
Several research analysts recently weighed in on the stock. Weiss Ratings reissued a “sell (e+)” rating on shares of 60 Degrees Pharmaceuticals in a research note on Friday, March 7th. HC Wainwright reissued a “neutral” rating on shares of 60 Degrees Pharmaceuticals in a research note on Tuesday, February 25th.
60 Degrees Pharmaceuticals Company Profile
60 Degrees Pharmaceuticals, Inc, a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal pneumonias, and candidiasis disease; and Celgosivir for respiratory viruses and dengue.
Featured Articles
- Five stocks we like better than 60 Degrees Pharmaceuticals
- Buy P&G Now, Before It Sets A New All-Time High
- Meta Platforms: Can LLaMA Drive Long-Term Stock Growth?
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- 3 Unique and Dominant Consumer Staples ETF Plays
- What is a Death Cross in Stocks?
- 3 Dividend Stocks Offering Higher Yields and Bullish Forecasts
Receive News & Ratings for 60 Degrees Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 60 Degrees Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.